Kuros Biosciences AG (CSBTF)
OTCMKTS · Delayed Price · Currency is USD
32.00
0.00 (0.00%)
Sep 4, 2025, 8:00 PM EDT
Kuros Biosciences AG Market Cap
Kuros Biosciences AG has a market cap or net worth of $1.25 billion as of September 5, 2025. Its market cap has increased by 77.32% in one year.
Market Cap
1.25B
Enterprise Value
1.23B
Revenue
129.96M
Ranking
n/a
PE Ratio
n/a
Stock Price
$32.00
Market Cap Chart
Since January 21, 2016, Kuros Biosciences AG's market cap has decreased from 3.21B to 1.25B, a decrease of -61.22%. That is a compound annual growth rate of -9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 1.25B | 40.28% |
| Dec 30, 2024 | 888.22M | 483.02% |
| Dec 29, 2023 | 152.35M | 162.24% |
| Dec 30, 2022 | 58.10M | -15.87% |
| Dec 30, 2021 | 69.06M | -7.89% |
| Dec 30, 2020 | 74.97M | 31.95% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Jan 21, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.42M |
| Veradigm | 840.66M |
| Elite Pharmaceuticals | 757.64M |
| Tian'an Technology Group | 660.01M |
| Glass House Brands | 561.06M |
| Northwest Biotherapeutics | 393.37M |
| CytoDyn | 391.17M |
| American Oncology Network | 361.55M |